Regulatory PathRegulatory requirements compared

Active substance

Docusate

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
DEWAX 5MG-ML OTIC DROPS5 %Ear drops · Auricular use1 Dropper ContainerSAR 6.45Generic · PrescriptionAmman Pharmaceutical Industries (API)Valid
WAXSOL0.5 %Ear drops · Auricular use1 BottleSAR 6.45Generic · PrescriptionRIYADH PHARMAValid
NORGALAX 0.12G-10G MICRO-ENEMA RECTLTUBE12 mg/mlRectal gel · Rectal use6 TubeSAR 16.40NCE · PrescriptionNORGINEWithdrawn by MAH · Not Marketed

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
COLACE0209016310 MG / MLSOLUTION · ORALPHARMASCIENCE INC
COLACE CAPSULES02106256100 MGCAPSULE · ORALPHARMASCIENCE INC
COLACE CLEAR02484226100 MGCAPSULE · ORALPHARMASCIENCE INC
COLACE SYRUP0208601820 MG / 5 MLSYRUP · ORALPHARMASCIENCE INC
DOCUSATE SODIUM02426838100 MGCAPSULE · ORALSANIS HEALTH INC
ENEMEEZ02526492283 MG / 5 MLENEMA · RECTALQUEST PRODUCTS, LLC
M-DOCUSATE SODIUM 100 MG02437317100 MGCAPSULE · ORALMANTRA PHARMA INC
PMS-DOCUSATE SODIUM00703494100 MGCAPSULE · ORALPHARMASCIENCE INC
RATIO-DOCUSATE SODIUM0087022620 MG / 5 MLSYRUP · ORALTEVA CANADA LIMITED
SELAX CAP 100MG00514888100 MGCAPSULE · ORALODAN LABORATORIESLTD
SIROP DOCUSATE DE SODIUM U.S.P. 4MG/ML0223828320 MG / 5 MLSYRUP · ORALLABORATOIRE ATLAS INC
SOFLAX CAPSULES 100MG01994344100 MGCAPSULE · ORALPHARMASCIENCE INC
STOOL SOFTENER02232969100 MGCAPSULE · ORALPERRIGO INTERNATIONAL
STOOL SOFTENER02281031100 MGCAPSULE · ORALPHARMASCIENCE INC
STOOL SOFTENER02357305100 MGCAPSULE · ORALVITA HEALTH PRODUCTS INC
STOOL SOFTENER CLEAR02536412100 MGCAPSULE · ORALVITA HEALTH PRODUCTS INC
TARO-DOCUSATE00716731100 MGCAPSULE · ORALTARO PHARMACEUTICALS INC

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACCOLACE 100 MG CAPSULE$0.30566per EA23 Sep 2026
US NADACCOLACE 2-IN-1 TABLET$0.41197per EA23 Sep 2026
US NADACCOLACE CLEAR 50 MG SOFTGEL$0.25629per EA20 May 2026
US NADACDOCUSATE SODIUM 100 MG SOFTGEL$0.02764per EA23 Sep 2026
US NADACDOCUSATE SODIUM 250 MG SOFTGEL$0.0523per EA23 Sep 2026
US NADACDOCUSATE SODIUM 50 MG/5 ML LIQ$0.02007per ML23 Sep 2026
US NADACFT STOOL SOFTENER 100 MG SFTGL$0.02764per EA23 Sep 2026
US NADACFT STOOL SOFTENER 100 MG TAB$0.03896per EA23 Sep 2026
US NADACFT STOOL SOFTENER 250 MG SFTGL$0.0523per EA23 Sep 2026
US NADACGNP STOOL SOFTENER 100 MG SFGL$0.02764per EA23 Sep 2026
US NADACGNP STOOL SOFTENER 250 MG SFGL$0.0523per EA23 Sep 2026
US NADACSTOOL SOFTENER 100 MG SOFTGEL$0.02764per EA23 Sep 2026
NHS Drug TariffDocusate 100mg capsules£3.2530 capsule1 Oct 2026
NHS Drug TariffDocusate 100mg capsules£7.2760 capsule1 Oct 2026
NHS Drug TariffDocusate 100mg capsules£11.39100 capsule1 Oct 2026
NHS Drug TariffDocusate 100mg/5ml oral solution sugar free£30.49150 ml1 Oct 2026
NHS Drug TariffDocusate 100mg/5ml oral solution sugar free£36.31300 ml1 Oct 2026
NHS Drug TariffDocusate 12.5mg/5ml oral solution sugar free£30.02300 ml1 Oct 2026
NHS Drug TariffDocusate 120mg/10g enema£28.006 enema1 Oct 2026
NHS Drug TariffDocusate 50mg/5ml oral solution sugar free£17.87300 ml1 Oct 2026
NHS Drug TariffDocusate sodium 0.5% ear drops£2.9310 ml1 Oct 2026
NHS Drug TariffDocusate sodium 5% ear drops£5.6015 ml1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

WHO WHO Model List of Essential Medicines (2025)

  • 2.3. Medicines for other common symptoms in palliative care · core
    Palliative care
    Oral > Liquid: 50 mg per 5 mL; 12.5 mg per 5 mL (EMLc) | Oral > Solid > capsule: 100 mg (EML)

Combinations containing Docusate

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.